Stavros G. Vizirgianakis bought $1.1M of XTNT
director at Xtant Medical Holdings, Inc.. 2,264,861 shares at an average of $0.48, traded Oct 7, 2022, filed Oct 11, 2022.
Score components
- +15RoleDirector
- +25Trade size$1.1M at market
- +10Relative to holdingsHoldings up 63%
- +8Price context44% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001235802-22-000113, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 7, 2022 | POpen-market purchase Common Stock, $0.000001 par value | +2,264,861 | $0.48 | $1.1M | 5,850,716 | Oct 11, 2022 |
| Oct 7, 2022 | POpen-market purchase Warrantderivative | +566,214 | $0.00 | $0 | 566,214 | Oct 11, 2022 |
Related signals
Other insiders at Xtant Medical Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | XTNTsell Xtant Medical Holdings, Inc. | Orbimed Advisors LLC owner | $31M 73,114,592 shares | -131% | |
| 25Weak | XTNTbuy Xtant Medical Holdings, Inc. | Kevin D Brandt Chief Commercial Officer | $50k 41,670 shares | +5% | |
| 14Weak | Xtant Medical Holdings, Inc. | Sean E Browne President and CEO | $86k 131,100 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.